Advisory Board

Dr. Andre Koltermann is a biotechnology entrepreneur, investor, and executive with more than 25 years of international leadership experience in life sciences, industrial biotechnology, and specialty chemicals. He co-founded Direvo Biotech AG, a pioneer in directed evolution technologies that was later acquired by Bayer Healthcare. In executive leadership positions at Süd-Chemie and Clariant, he led the development and commercialization of breakthrough biotechnology solutions. He has founded and co-founded several technology-driven companies, including Syntab Therapeutics and Efficient Robotics. Today, he advises and invests in early-stage ventures at the intersection of biotechnology and advanced technologies. At Syntab, he is the inventor of the company’s core technology platform and serves as Chairman of the Advisory Board.

Matthias Brede is a business administration graduate and certified public accountant with extensive experience in tax consulting, management consulting, and corporate governance. He studied mathematics and business administration in Göttingen and has been a certified public accountant since 1992. Since 1993, he has been a partner at am Nonnenstieg, PartGmbB, a tax consulting firm in Göttingen. Since January 2025, he has been working as a freelance management consultant. He also serves on the boards of nonprofit foundations and associations and is currently a member of several supervisory and advisory boards.

Dr. Guido Komatsu studied history, law, and philosophy, earning a doctorate in legal history, and has more than 25 years of executive experience in real asset investments. He is Managing Partner of Quarterdeck GmbH & Co. KG, a Hamburg-based investment firm. Previously, he served as managing partner of an asset management firm, managing partner of a consulting firm for institutional investors, and as a board member of various asset management companies.